Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Howard A. Burris
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab With Taxane for Human Epidermal Growth Factor Receptor 2–positive Advanced Breast Cancer: Final Results From MARIANNE
Cancer
Cancer Research
Oncology
A Phase I Study of Weekly Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
Oncologist
Cancer Research
Medicine
Oncology
Ribociclib With Letrozole vs Letrozole Alone in Elderly Patients With Hormone Receptor-Positive, HER2-negative Breast Cancer in the Randomized MONALEESA-2 Trial
Breast Cancer Research and Treatment
Cancer Research
Oncology
Erratum To: A Phase I Dose-Escalation Study of Selumetinib in Combination With Erlotinib or Temsirolimus in Patients With Advanced Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
A Phase I Dose-Escalation Study of Selumetinib in Combination With Docetaxel or Dacarbazine in Patients With Advanced Solid Tumors
BMC Cancer
Cancer Research
Oncology
Genetics
Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
O3-2-5a Phase I Trial of BI 754091, a Programmed Death Receptor 1 (PD-1) Inhibitor, in Patients With Advanced Solid Tumors
Annals of Oncology
Medicine
Oncology
Hematology
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Topotecan: Incorporating It Into the Treatment of Solid Tumors
Oncologist
Cancer Research
Medicine
Oncology
